New insights into cellular processes after a stroke

In order to investigate the activity of individual cells in the brain after a stroke, the research team led by first author Daniel Bormann (Department of Thoracic Surgery) and study leaders Hendrik J. Ankersmit (Department of Thoracic Surgery) and Michael Mildner (Department of Dermatology) used single-cell RNA sequencing in animal models, which are already established in stroke research. Using this method, the researchers were able to identify different cell types and their reactions in the early phase after a cerebral infarction. They focussed on two specific cell types (astrocytes and oligodentrocytes) from the group of glial cells, which are involved in many fundamental processes in the brain.

Cellular interaction in the infarct area

Scientists already know that astrocytes divide rapidly after a stroke and accumulate around the infarct area.

“We have been able to show, that oligodentrocyte precursor cells also divide in the acute infarct phase and accumulate at the edge of the damaged nerve tissue,” reports Daniel Bormann. In further complex analyses, the scientists discovered possible mechanisms in the wound healing of the damaged brain area: “We found considerable overlaps in the gene activity patterns of both cell types, especially in those genes that are important for building the glial barrier around the infarct,” Bormann explains a remarkable detail from the study.

In addition, it was discovered that certain immune cells (microglia and macrophages), which are also found in the vicinity of the infarct, release a signalling molecule (osteopontin). This molecule could play a decisive role in directing the glial cells to the edge of the infarct, where they are needed, among other functions, to form a barrier between the damaged and healthy tissue. “Our description of the interaction between immune and glial cells in the infarct area contributes considerably to a better understanding of the regeneration processes of nerve tissue in the brain after a stroke,” says Daniel Bormann, summarising the significance of the results.

After cardiovascular diseases and cancer, strokes are the third most common cause of death in Austria and the most frequent cause of permanent disability and the need for long-term care. An ischaemic stroke is caused by the blockage of a blood vessel in the brain. The resulting interruption in the supply of oxygen and nutrients leads to a cerebral infarction in which nerve tissue is irreversibly damaged. Treatment approaches to date focus on restoring blood flow, which has to happen within 24 hours and is only possible for part of those affected. As the cellular processes following a cerebral infarction are not yet fully understood, treatment approaches to promote the regeneration of nerve tissue after a stroke are still lacking.

“The insights gained in our international and interdisciplinary study are a promising resource for developing novel targeted therapeutic strategies,” says Daniel Bormann with a view to further scientific investigations.